Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in NVCT — Nuvectis Pharma, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to NVCT Full portfolio

Position in NVCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$286,773
+$243,340 QoQ
Shares Held
15,594
+177.5% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 82 holders
Holding Since
Mar 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. NVCT ranks #223 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in NVCT

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $286,773 15,594
2026-03-31 $43,433 5,619
2025-12-31 $127,813 16,929
2025-09-30 $47,599 7,907
2025-06-30 $49,697 6,653
2024-03-31 $18,040 2,200
2023-12-31 $15,862 1,902
2023-09-30 $18,883 1,465
2023-06-30 $45,434 2,845
2023-03-31 $327 25
2022-12-31 $187 25
2022-09-30 $170 24
2022-06-30 $235 21
2022-03-31 $148 20